The Fagerstrom Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST)

被引：144
作者：
Ebbert, Jon O.
Patten, Christi A.
Schroeder, Darrell R.
机构：
[1] Mayo Clin, Dept Internal Med, Nicotine Res Program, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Hlth Sci Res, Div Biostat, Rochester, MN 55905 USA
来源：
ADDICTIVE BEHAVIORS | 2006年 / 31卷 / 09期
关键词：
smokeless tobacco; tobacco use disorder; tobacco alkaloid; nicotine; dependence measure;
D O I：
10.1016/j.addbeh.2005.12.015
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
Few nicotine dependence measures have been developed for smokeless tobacco (ST) users. Existing measures are limited by the requirement to rate the nicotine content of ST brands for which data is scarce or non-existent. We modified the Fagerstrom Test for Nicotine Dependence (FTND) for ST users, referred to this scale as the FTND-ST, and evaluated its characteristics in a population of 42 ST users. The correlation between the FTND-ST total score and the serum cotinine concentrations was 0.53 (p < 0.001). Internal consistency reliability assessed using the coefficient alpha was 0.47. Correlations and the coefficient alpha are similar to those reported for commonly used nicotine dependence measures. Development and refinement of nicotine dependence measures for ST users are essential steps in order to advance the field of ST research. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1716 / 1721
页数：6
相关论文
共 16 条
  • [1] MEASURING DEPENDENCE IN SMOKELESS TOBACCO USERS
    BOYLE, RG
    JENSEN, J
    HATSUKAMI, DK
    SEVERSON, HH
    [J]. ADDICTIVE BEHAVIORS, 1995, 20 (04) : 443 - 450
  • [2] Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P398
  • [3] Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
  • [4] THE PHARMACOKINETICS OF COTININE IN PLASMA AND SALIVA FROM NONSMOKING HEALTHY-VOLUNTEERS
    CURVALL, M
    ELWIN, CE
    KAZEMIVALA, E
    WARHOLM, C
    ENZELL, CR
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (03) : 281 - 287
  • [5] Djordjevic M. V., 1995, TOB CONTROL, V4, P62, DOI DOI 10.1136/TC.4.1.62
  • [6] A survey of characteristics of smokeless tobacco users in a treatment program
    Ebbert, JO
    Klinkhammer, MD
    Stevens, SR
    Rowland, LC
    Offord, KP
    Ames, SC
    Dale, LC
    [J]. AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2005, 29 (01) : 25 - 35
  • [7] Residential treatment for smokeless tobacco use: A case series
    Ebbert, JO
    Dale, LC
    Vickers, KS
    Gauvin, TR
    Bunge, NE
    Hurt, RD
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2004, 26 (04) : 261 - 267
  • [8] Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users
    Ebbert, JO
    Dale, LC
    Nirelli, LM
    Schroeder, DR
    Moyer, TP
    Hurt, RD
    [J]. ADDICTIVE BEHAVIORS, 2004, 29 (02) : 349 - 355
  • [9] MEASURING NICOTINE DEPENDENCE - A REVIEW OF THE FAGERSTROM TOLERANCE QUESTIONNAIRE
    FAGERSTROM, KO
    SCHNEIDER, NG
    [J]. JOURNAL OF BEHAVIORAL MEDICINE, 1989, 12 (02) : 159 - 182
  • [10] MEASURING DEGREE OF PHYSICAL-DEPENDENCE TO TOBACCO SMOKING WITH REFERENCE TO INDIVIDUALIZATION OF TREATMENT
    FAGERSTROM, KO
    [J]. ADDICTIVE BEHAVIORS, 1978, 3 (3-4) : 235 - 241
12